{"id":2507,"date":"2025-07-14T21:03:45","date_gmt":"2025-07-14T21:03:45","guid":{"rendered":"https:\/\/www.donyoomd.com\/blog\/?p=2507"},"modified":"2025-07-14T21:03:45","modified_gmt":"2025-07-14T21:03:45","slug":"the-latest-fda-approved-neuromodulator-letybo","status":"publish","type":"post","link":"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/","title":{"rendered":"The Latest FDA Approved Neuromodulator Letybo"},"content":{"rendered":"<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"773\" src=\"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406-1024x773.jpg\" alt=\"\" class=\"wp-image-2099\" style=\"width:633px;height:auto\" srcset=\"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406-1024x773.jpg 1024w, https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406-300x227.jpg 300w, https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406-768x580.jpg 768w, https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406.jpg 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\">Masseter reduction with Botox or Letybo<\/figcaption><\/figure>\n<\/div>\n\n\n<p><strong>Letybo<\/strong> (letibotulinumtoxinA) is a newer botulinum toxin type A formulation developed by Hugel, a South Korean biopharmaceutical company. It joins a growing list of botulinum neurotoxin serotype A (BoNT-A) products used in aesthetic and therapeutic medicine. The primary competitors of Letybo include onabotulinumtoxinA (Botox\u00ae), abobotulinumtoxinA (Dysport\u00ae), incobotulinumtoxinA (Xeomin\u00ae), and prabotulinumtoxinA (Jeuveau\u00ae). The following is a comparative analysis based on current scientific literature and available clinical data:<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>1. Molecular Composition &amp; Formulation<\/strong><\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Product<\/th><th>Active Ingredient<\/th><th>Complexing Proteins<\/th><th>Manufacturing Origin<\/th><\/tr><\/thead><tbody><tr><td><strong>Letybo<\/strong><\/td><td>LetibotulinumtoxinA<\/td><td>Yes (similar to Botox)<\/td><td>Hugel (South Korea)<\/td><\/tr><tr><td><strong>Botox<\/strong><\/td><td>OnabotulinumtoxinA<\/td><td>Yes (900 kDa complex)<\/td><td>Allergan (AbbVie)<\/td><\/tr><tr><td><strong>Dysport<\/strong><\/td><td>AbobotulinumtoxinA<\/td><td>Yes (500\u2013900 kDa complex)<\/td><td>Ipsen\/Galderma<\/td><\/tr><tr><td><strong>Xeomin<\/strong><\/td><td>IncobotulinumtoxinA<\/td><td>No (naked toxin)<\/td><td>Merz<\/td><\/tr><tr><td><strong>Jeuveau<\/strong><\/td><td>PrabotulinumtoxinA<\/td><td>Yes<\/td><td>Evolus (Daewoong)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Implication:<\/strong> The presence of complexing proteins may affect immunogenicity and diffusion, although clinical relevance is still debated. Letybo is structurally similar to Botox, both being 900 kDa complexes.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>2. Potency and Dose Equivalence<\/strong><\/h3>\n\n\n\n<p>Letybo&#8217;s units are not bioequivalent to other BoNT-As on a 1:1 basis, but early studies suggest its clinical potency is <strong>comparable to Botox<\/strong> when administered at equal unit doses.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Product<\/th><th>Approximate Conversion Ratio to Botox<\/th><\/tr><\/thead><tbody><tr><td>Letybo<\/td><td>1:1 (preliminary clinical data)<\/td><\/tr><tr><td>Dysport<\/td><td>~2.5\u20133:1<\/td><\/tr><tr><td>Xeomin<\/td><td>1:1<\/td><\/tr><tr><td>Jeuveau<\/td><td>1:1<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>3. Clinical Efficacy<\/strong><\/h3>\n\n\n\n<p>Most studies on Letybo focus on <strong>glabellar line treatment<\/strong>, with Phase III trials conducted in Asian and, more recently, European populations.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Efficacy Onset:<\/strong> Similar to Botox (2\u20133 days).<\/li>\n\n\n\n<li><strong>Peak Effect:<\/strong> 1\u20132 weeks post-injection.<\/li>\n\n\n\n<li><strong>Duration:<\/strong> ~12\u201316 weeks (comparable to Botox and Jeuveau).<\/li>\n<\/ul>\n\n\n\n<p><strong>Head-to-head data<\/strong> comparing Letybo with Botox or other agents in diverse populations (especially non-Asian) are currently limited. A Korean Phase III study (Lee et al., <em>Dermatol Ther<\/em>, 2021) found <strong>non-inferiority to Botox<\/strong> for glabellar lines at week 4.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>4. Safety and Adverse Event Profile<\/strong><\/h3>\n\n\n\n<p>Letybo has shown a favorable safety profile consistent with other BoNT-As in trials. No unique adverse effects have been reported.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Common AEs<\/th><th>All Products (Including Letybo)<\/th><\/tr><\/thead><tbody><tr><td>Headache<\/td><td>Yes<\/td><\/tr><tr><td>Eyelid ptosis<\/td><td>Yes<\/td><\/tr><tr><td>Local injection site reactions<\/td><td>Yes<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>5. Immunogenicity<\/strong><\/h3>\n\n\n\n<p>Theoretically, toxins without complexing proteins (e.g., Xeomin) might have <strong>lower antigenicity<\/strong>, but clinically relevant immunogenicity remains low across all BoNT-As when used in aesthetic doses. No long-term data yet confirm differences in neutralizing antibody development for Letybo.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>6. Regulatory &amp; Market Access<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Letybo:<\/strong> Approved in South Korea, China, Canada, and EU (2022). FDA approved (2024) in the U.S.<\/li>\n\n\n\n<li><strong>Botox\/Xeomin\/Dysport\/Jeuveau:<\/strong> All approved in U.S. and globally widespread.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>7. Cost and Economic Consideration<\/strong><\/h3>\n\n\n\n<p>Letybo has been marketed as a <strong>cost-effective alternative<\/strong> in regions like South Korea and China. Its competitive pricing may drive adoption, particularly in aesthetic markets sensitive to cost margins.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Conclusion<\/strong><\/h3>\n\n\n\n<p><strong>Letybo<\/strong> is a <strong>viable alternative<\/strong> to existing BoNT-A products with comparable efficacy, safety, and pharmacologic properties, particularly similar to Botox in terms of molecular weight and clinical onset\/duration. However, due to its <strong>limited longitudinal data<\/strong> and fewer global head-to-head trials, particularly in diverse patient populations, broader clinical acceptance (especially in Western markets) may depend on further <strong>robust, comparative trials<\/strong> and <strong>real-world experience<\/strong>.<\/p>\n<p><span class='st_facebook' st_title='The Latest FDA Approved Neuromodulator Letybo' st_url='https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/'><\/span><span class='st_twitter' st_title='The Latest FDA Approved Neuromodulator Letybo' st_url='https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/'><\/span><span class='st_linkedin' st_title='The Latest FDA Approved Neuromodulator Letybo' st_url='https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/'><\/span><span class='st_email' st_title='The Latest FDA Approved Neuromodulator Letybo' st_url='https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/'><\/span><span class='st_sharethis' st_title='The Latest FDA Approved Neuromodulator Letybo' st_url='https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/'><\/span><span class='st_fblike' st_title='The Latest FDA Approved Neuromodulator Letybo' st_url='https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/'><\/span><span class='st_plusone' st_title='The Latest FDA Approved Neuromodulator Letybo' st_url='https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/'><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Letybo (letibotulinumtoxinA) is a newer botulinum toxin type A formulation developed by Hugel, a South Korean biopharmaceutical company. It joins a growing list of botulinum neurotoxin serotype A (BoNT-A) products used in aesthetic and therapeutic medicine. The primary competitors of &hellip; <a href=\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/\">Continue reading <span class=\"meta-nav\">&#x2B62;<\/span><\/a><\/p>\n<p><span class='st_facebook' st_title='The Latest FDA Approved Neuromodulator Letybo' st_url='https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/'><\/span><span class='st_twitter' st_title='The Latest FDA Approved Neuromodulator Letybo' st_url='https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/'><\/span><span class='st_linkedin' st_title='The Latest FDA Approved Neuromodulator Letybo' st_url='https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/'><\/span><span class='st_email' st_title='The Latest FDA Approved Neuromodulator Letybo' st_url='https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/'><\/span><span class='st_sharethis' st_title='The Latest FDA Approved Neuromodulator Letybo' st_url='https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/'><\/span><span class='st_fblike' st_title='The Latest FDA Approved Neuromodulator Letybo' st_url='https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/'><\/span><span class='st_plusone' st_title='The Latest FDA Approved Neuromodulator Letybo' st_url='https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/'><\/span><\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2507","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Latest FDA Approved Neuromodulator Letybo - Beverly Hills Facial Plastic Surgery - Donald B. Yoo M.D.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Latest FDA Approved Neuromodulator Letybo - Beverly Hills Facial Plastic Surgery - Donald B. Yoo M.D.\" \/>\n<meta property=\"og:description\" content=\"Letybo (letibotulinumtoxinA) is a newer botulinum toxin type A formulation developed by Hugel, a South Korean biopharmaceutical company. It joins a growing list of botulinum neurotoxin serotype A (BoNT-A) products used in aesthetic and therapeutic medicine. The primary competitors of &hellip; Continue reading &#x2B62;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/\" \/>\n<meta property=\"og:site_name\" content=\"Beverly Hills Facial Plastic Surgery - Donald B. Yoo M.D.\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-14T21:03:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"906\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donald B. Yoo, M.D.\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DrDonYoo\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donald B. Yoo, M.D.\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/\"},\"author\":{\"name\":\"Donald B. Yoo, M.D.\",\"@id\":\"https:\/\/www.donyoomd.com\/blog\/#\/schema\/person\/03946a4a3c227f4bf4a232cdfbb60426\"},\"headline\":\"The Latest FDA Approved Neuromodulator Letybo\",\"datePublished\":\"2025-07-14T21:03:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/\"},\"wordCount\":480,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.donyoomd.com\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406-1024x773.jpg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/\",\"url\":\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/\",\"name\":\"The Latest FDA Approved Neuromodulator Letybo - Beverly Hills Facial Plastic Surgery - Donald B. Yoo M.D.\",\"isPartOf\":{\"@id\":\"https:\/\/www.donyoomd.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406-1024x773.jpg\",\"datePublished\":\"2025-07-14T21:03:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#primaryimage\",\"url\":\"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406.jpg\",\"contentUrl\":\"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406.jpg\",\"width\":1200,\"height\":906,\"caption\":\"Masseter reduction with Botox or Letybo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.donyoomd.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Latest FDA Approved Neuromodulator Letybo\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.donyoomd.com\/blog\/#website\",\"url\":\"https:\/\/www.donyoomd.com\/blog\/\",\"name\":\"Beverly Hills Facial Plastic Surgery - Donald B. Yoo M.D.\",\"description\":\"Pretty to Prettier\",\"publisher\":{\"@id\":\"https:\/\/www.donyoomd.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.donyoomd.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.donyoomd.com\/blog\/#organization\",\"name\":\"Beverly Hills Facial Plastic Surgery - Donald B. Yoo M.D.\",\"url\":\"https:\/\/www.donyoomd.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.donyoomd.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2012\/12\/DYlogo.jpg\",\"contentUrl\":\"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2012\/12\/DYlogo.jpg\",\"width\":\"165\",\"height\":\"180\",\"caption\":\"Beverly Hills Facial Plastic Surgery - Donald B. Yoo M.D.\"},\"image\":{\"@id\":\"https:\/\/www.donyoomd.com\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.donyoomd.com\/blog\/#\/schema\/person\/03946a4a3c227f4bf4a232cdfbb60426\",\"name\":\"Donald B. Yoo, M.D.\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.donyoomd.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/85f6b64ff13fb4f678066615ab70739a6b698e8b5338a0dd33a36be3efdbdf3b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/85f6b64ff13fb4f678066615ab70739a6b698e8b5338a0dd33a36be3efdbdf3b?s=96&d=mm&r=g\",\"caption\":\"Donald B. Yoo, M.D.\"},\"description\":\"Dr. Yoo is a board-certified surgeon, fellowship trained in facial plastic surgery with extensive experience in cosmetic and reconstructive surgery. He specializes in rhinoplasty, revision rhinoplasty, facial rejuvenation surgery (including blepharoplasty and facelift), and Asian cosmetic surgery (including Asian rhinoplasty and Asian blepharoplasty\/Asian eyelid surgery). see more: https:\/\/donyoomd.com 433 N Camden Drive, Suite 970 Beverly Hills, CA 90210 310-772-0766\",\"sameAs\":[\"https:\/\/donyoomd.com\",\"https:\/\/x.com\/DrDonYoo\"],\"url\":\"https:\/\/www.donyoomd.com\/blog\/author\/donyoo\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Latest FDA Approved Neuromodulator Letybo - Beverly Hills Facial Plastic Surgery - Donald B. Yoo M.D.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/","og_locale":"en_US","og_type":"article","og_title":"The Latest FDA Approved Neuromodulator Letybo - Beverly Hills Facial Plastic Surgery - Donald B. Yoo M.D.","og_description":"Letybo (letibotulinumtoxinA) is a newer botulinum toxin type A formulation developed by Hugel, a South Korean biopharmaceutical company. It joins a growing list of botulinum neurotoxin serotype A (BoNT-A) products used in aesthetic and therapeutic medicine. The primary competitors of &hellip; Continue reading &#x2B62;","og_url":"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/","og_site_name":"Beverly Hills Facial Plastic Surgery - Donald B. Yoo M.D.","article_published_time":"2025-07-14T21:03:45+00:00","og_image":[{"width":1200,"height":906,"url":"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406.jpg","type":"image\/jpeg"}],"author":"Donald B. Yoo, M.D.","twitter_card":"summary_large_image","twitter_creator":"@DrDonYoo","twitter_misc":{"Written by":"Donald B. Yoo, M.D.","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#article","isPartOf":{"@id":"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/"},"author":{"name":"Donald B. Yoo, M.D.","@id":"https:\/\/www.donyoomd.com\/blog\/#\/schema\/person\/03946a4a3c227f4bf4a232cdfbb60426"},"headline":"The Latest FDA Approved Neuromodulator Letybo","datePublished":"2025-07-14T21:03:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/"},"wordCount":480,"commentCount":0,"publisher":{"@id":"https:\/\/www.donyoomd.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406-1024x773.jpg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/","url":"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/","name":"The Latest FDA Approved Neuromodulator Letybo - Beverly Hills Facial Plastic Surgery - Donald B. Yoo M.D.","isPartOf":{"@id":"https:\/\/www.donyoomd.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#primaryimage"},"image":{"@id":"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406-1024x773.jpg","datePublished":"2025-07-14T21:03:45+00:00","breadcrumb":{"@id":"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#primaryimage","url":"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406.jpg","contentUrl":"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2023\/05\/KV-Masseter-reduction-frontal-view-regular-size-scaled-e1683405576406.jpg","width":1200,"height":906,"caption":"Masseter reduction with Botox or Letybo"},{"@type":"BreadcrumbList","@id":"https:\/\/www.donyoomd.com\/blog\/2025\/07\/14\/the-latest-fda-approved-neuromodulator-letybo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.donyoomd.com\/blog\/"},{"@type":"ListItem","position":2,"name":"The Latest FDA Approved Neuromodulator Letybo"}]},{"@type":"WebSite","@id":"https:\/\/www.donyoomd.com\/blog\/#website","url":"https:\/\/www.donyoomd.com\/blog\/","name":"Beverly Hills Facial Plastic Surgery - Donald B. Yoo M.D.","description":"Pretty to Prettier","publisher":{"@id":"https:\/\/www.donyoomd.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.donyoomd.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.donyoomd.com\/blog\/#organization","name":"Beverly Hills Facial Plastic Surgery - Donald B. Yoo M.D.","url":"https:\/\/www.donyoomd.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.donyoomd.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2012\/12\/DYlogo.jpg","contentUrl":"https:\/\/www.donyoomd.com\/blog\/wp-content\/uploads\/2012\/12\/DYlogo.jpg","width":"165","height":"180","caption":"Beverly Hills Facial Plastic Surgery - Donald B. Yoo M.D."},"image":{"@id":"https:\/\/www.donyoomd.com\/blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.donyoomd.com\/blog\/#\/schema\/person\/03946a4a3c227f4bf4a232cdfbb60426","name":"Donald B. Yoo, M.D.","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.donyoomd.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/85f6b64ff13fb4f678066615ab70739a6b698e8b5338a0dd33a36be3efdbdf3b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/85f6b64ff13fb4f678066615ab70739a6b698e8b5338a0dd33a36be3efdbdf3b?s=96&d=mm&r=g","caption":"Donald B. Yoo, M.D."},"description":"Dr. Yoo is a board-certified surgeon, fellowship trained in facial plastic surgery with extensive experience in cosmetic and reconstructive surgery. He specializes in rhinoplasty, revision rhinoplasty, facial rejuvenation surgery (including blepharoplasty and facelift), and Asian cosmetic surgery (including Asian rhinoplasty and Asian blepharoplasty\/Asian eyelid surgery). see more: https:\/\/donyoomd.com 433 N Camden Drive, Suite 970 Beverly Hills, CA 90210 310-772-0766","sameAs":["https:\/\/donyoomd.com","https:\/\/x.com\/DrDonYoo"],"url":"https:\/\/www.donyoomd.com\/blog\/author\/donyoo\/"}]}},"_links":{"self":[{"href":"https:\/\/www.donyoomd.com\/blog\/wp-json\/wp\/v2\/posts\/2507","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.donyoomd.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.donyoomd.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.donyoomd.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.donyoomd.com\/blog\/wp-json\/wp\/v2\/comments?post=2507"}],"version-history":[{"count":1,"href":"https:\/\/www.donyoomd.com\/blog\/wp-json\/wp\/v2\/posts\/2507\/revisions"}],"predecessor-version":[{"id":2508,"href":"https:\/\/www.donyoomd.com\/blog\/wp-json\/wp\/v2\/posts\/2507\/revisions\/2508"}],"wp:attachment":[{"href":"https:\/\/www.donyoomd.com\/blog\/wp-json\/wp\/v2\/media?parent=2507"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.donyoomd.com\/blog\/wp-json\/wp\/v2\/categories?post=2507"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.donyoomd.com\/blog\/wp-json\/wp\/v2\/tags?post=2507"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}